✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Brooks Laboratories Ltd.

BROOKS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹280 Cr.
P/E
24.29

Brooks Laboratories Ltd.

  • Brooks Laboratories
  • Vaidya Sane Ayur Lab
  • Lyka Labs

FAQs on Brooks Laboratories Ltd. Shareprice

Brooks Laboratories has given lower returns compared to its competitors.
Brooks Laboratories has grown at ~-6.92% over the last 3yrs while peers have grown at a median rate of -0.93%

Brooks Laboratories is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Brooks Laboratories is 25.4, while 3 year average PE is 0.81.
Also latest EV/EBITDA of Brooks Laboratories is 32.99 while 3yr average is 72.01.

View FAQ's On Business

Growth Table

  • Brooks Laboratories Ltd.
  • Vaidya Sane Ayur Lab
  • Lyka Labs

Balance Sheet

  • Brooks Laboratories Ltd.
  • Vaidya Sane Ayur Lab
  • Lyka Labs

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Brooks Laboratories Ltd.
  • Vaidya Sane Ayur Lab
  • Lyka Labs

Cash Flow

  • Brooks Laboratories Ltd.
  • Vaidya Sane Ayur Lab
  • Lyka Labs

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Brooks Laboratories Ltd.
  • Vaidya Sane Ayur Lab
  • Lyka Labs

Quarterly Results

  • Brooks Laboratories Ltd.
  • Vaidya Sane Ayur Lab
  • Lyka Labs

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Brooks Laboratories Ltd. Financials

Balance sheet of Brooks Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Brooks Laboratories is increasing.
Latest net debt of Brooks Laboratories is ₹5.4 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹3.58 Crs.

Yes, profit is increasing.
The profit of Brooks Laboratories is ₹6.92 Crs for TTM, -₹9.97 Crs for Mar 2025 and -₹19.59 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Brooks Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech